|
2015 Journal Article A novel transducible chimeric phage from Escherichia coli O157: H7 Sakai strain encoding Stx1 productionSváb, Domonkos, Bálint, Balázs, Maróti, Gergely and Tóth, István (2015). A novel transducible chimeric phage from Escherichia coli O157: H7 Sakai strain encoding Stx1 production. Infection, Genetics and Evolution, 29, 42-47. doi: 10.1016/j.meegid.2014.10.019 |
|
2015 Journal Article Self-assembling lipopeptides with a potent activity against Gram-positive bacteria, including multidrug resistant strainsAzmi, Fazren, Elliott, Alysha G., Khalil, Zeinab G., Hussein, Waleed M., Kavanagh, Angela, Huang, Johnny X., Quezada, Michelle, Blaskovich, Mark A. T., Capon, Robert J., Cooper, Matthew A., Skwarczynski, Mariusz and Toth, Istvan (2015). Self-assembling lipopeptides with a potent activity against Gram-positive bacteria, including multidrug resistant strains. Nanomedicine, 10 (22), 3359-3371. doi: 10.2217/nnm.15.137 |
|
2015 Journal Article Self-adjuvanting therapeutic peptide-based vaccine induce CD8+ cytotoxic T lymphocyte responses in a murine human papillomavirus tumor modelLiu, Tzu-Yu, Giddam, Ashwini Kumar, Hussein, Waleed M., Jia, Zhongfan, McMillan, Nigel A. J., Monteiro, Michael J., Toth, Istvan and Skwarczynski, Mariusz (2015). Self-adjuvanting therapeutic peptide-based vaccine induce CD8+ cytotoxic T lymphocyte responses in a murine human papillomavirus tumor model. Current Drug Delivery, 12 (1), 3-8. doi: 10.2174/1567201811666141001155729 |
|
2015 Journal Article Meet our editorial board memberToth, Istvan (2015). Meet our editorial board member. Current Drug Delivery, 12 (2), 121-121. doi: 10.2174/156720181202150423103624 |
|
2014 Journal Article Biophysical characterization of lectin-glycan interactions for therapeutics, vaccines and targeted drug-delivery.Christie, Michelle P., Toth, Istvan and Simerska, Pavla (2014). Biophysical characterization of lectin-glycan interactions for therapeutics, vaccines and targeted drug-delivery.. Future Medicinal Chemistry, 6 (18), 2113-2129. doi: 10.4155/fmc.14.130 |
|
2014 Journal Article Recent advances in peptide-based subunit nanovaccinesSkwarczynski, Mariusz and Toth, Istvan (2014). Recent advances in peptide-based subunit nanovaccines. Nanomedicine, 9 (17), 2657-2669. doi: 10.2217/nnm.14.187 |
|
2014 Journal Article The contribution of non-human primate models to the development of human vaccinesRivera-Hernandez, Tania, Carnathan, Diane G., Moyle, Peter M., Toth, Istvan, West, Nicholas P., Young, Paul L., Silvestri, Guido and Walker, Mark J. (2014). The contribution of non-human primate models to the development of human vaccines. Discovery Medicine, 18 (101), 313-322. |
|
2014 Journal Article Enhanced transdermal peptide delivery and stability by lipid conjugation: epidermal permeation, stereoselectivity and mechanistic insightsNamjoshi, Sarika, Toth, Istvan, Blanchfield, Joanne T., Trotter, Nicholas, Mancera, Ricardo L. and Benson, Heather A. E. (2014). Enhanced transdermal peptide delivery and stability by lipid conjugation: epidermal permeation, stereoselectivity and mechanistic insights. Pharmaceutical Research, 31 (12), 3304-3312. doi: 10.1007/s11095-014-1420-5 |
|
2014 Journal Article Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicityZaman, Mehfuz, Chandrudu, Saranya, Giddam, Ashwini K., Reiman, Jennifer, Skwarczynski, Mariusz, McPhun, Virginia, Moyle, Peter M., Batzloff, Michael R., Good, Michael F. and Toth, Istvan (2014). Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity. Nanomedicine, 9 (17), 2613-2624. doi: 10.2217/NNM.14.190 |
|
2014 Journal Article Self-adjuvanting vaccine against group A streptococcus: application of fibrillized peptide and immunostimulatory lipid as adjuvantAzmi, Fazren, Ahmad Fuaad, Abdullah Al Hadi, Giddam, Ashwini Kumar, Batzloff, Michael R., Good, Michael F., Skwarczynski, Mariusz and Toth, Istvan (2014). Self-adjuvanting vaccine against group A streptococcus: application of fibrillized peptide and immunostimulatory lipid as adjuvant. Bioorganic and Medicinal Chemistry, 22 (22), 6401-6408. doi: 10.1016/j.bmc.2014.09.042 |
|
2014 Journal Article Stability, Permeability and Growth-Inhibitory Properties of Gonadotropin-Releasing Hormone LiposaccharidesGoodwin, Daryn, Varamini, Pegah, Simerska, Pavla and Toth, Istvan (2014). Stability, Permeability and Growth-Inhibitory Properties of Gonadotropin-Releasing Hormone Liposaccharides. Pharmaceutical Research, 32 (5), 1570-1584. doi: 10.1007/s11095-014-1558-1 |
|
2014 Journal Article Targeting the mannose receptor with mannosylated subunit vaccinesSedaghat, B., Stephenson, R. and Toth, I. (2014). Targeting the mannose receptor with mannosylated subunit vaccines. Current Medicinal Chemistry, 21 (30), 3405-3418. doi: 10.2174/0929867321666140826115552 |
|
2014 Journal Article Schistosome vaccine adjuvants in preclinical and clinical researchStephenson, Rachel, You, Hong, McManus, Donald P. and Toth, Istvan (2014). Schistosome vaccine adjuvants in preclinical and clinical research. Vaccines, 2 (3), 654-685. doi: 10.3390/vaccines2030654 |
|
2014 Journal Article Active immunisation of mice with GnRH lipopeptide vaccine candidates: importance of T helper or multi-dimer GnRH epitopeGoodwin, Daryn, Simerska, Pavla, Chang, Cheng-Hung, Mansfeld, Friederike M., Varamini, Pegah, D'Occhio, Michael J. and Toth, Istvan (2014). Active immunisation of mice with GnRH lipopeptide vaccine candidates: importance of T helper or multi-dimer GnRH epitope. Bioorganic and Medicinal Chemistry, 22 (17), 4848-4854. doi: 10.1016/j.bmc.2014.06.052 |
|
2014 Conference Publication Glycosylation of Luteinizing Hormone Releasing Hormone: Towards the Development of Orally Active PeptidesMoradi, S. V., Varamini, P. and Toth, I. (2014). Glycosylation of Luteinizing Hormone Releasing Hormone: Towards the Development of Orally Active Peptides. HOBOKEN: WILEY. |
|
2014 Journal Article The transport and efflux of glycosylated luteinising hormone-releasing hormone analogues in Caco-2 cell model: contributions of glucose transporters and efflux systemsMoradi, Shayli Varasteh, Varamini, Pegah and Toth, Istvan (2014). The transport and efflux of glycosylated luteinising hormone-releasing hormone analogues in Caco-2 cell model: contributions of glucose transporters and efflux systems. Journal of Pharmaceutical Sciences, 103 (10), 3217-3224. doi: 10.1002/jps.24120 |
|
2014 Journal Article Oral delivery of nanoparticle-based vaccinesMarasini, Nirmal, Skwarczynski, Mariusz and Toth, Istvan (2014). Oral delivery of nanoparticle-based vaccines. Expert Review of Vaccines, Early Online (11), 1361-1376. doi: 10.1586/14760584.2014.936852 |
|
2014 Journal Article Effect of lipidated gonadotropin-releasing hormone peptides on receptor mediated binding and uptake into prostate cancer cells in vitroStephenson, Rachel, Varamini, Pegah, Butcher, Neville, Minchin, Rodney and Toth, Istvan (2014). Effect of lipidated gonadotropin-releasing hormone peptides on receptor mediated binding and uptake into prostate cancer cells in vitro. Nanomedicine: Nanotechnology, Biology and Medicine, 10 (8), 1799-1808. doi: 10.1016/j.nano.2014.06.015 |
|
2014 Journal Article Convergent synthetic methodology for the construction of self-adjuvanting lipopeptide vaccines using a novel carbohydrate scaffoldFagan, Vincent, Toth, Istvan and Simerska, Pavla (2014). Convergent synthetic methodology for the construction of self-adjuvanting lipopeptide vaccines using a novel carbohydrate scaffold. Beilstein Journal of Organic Chemistry, 10 (1), 1741-1748. doi: 10.3762/bjoc.10.181 |
|
2014 Journal Article Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group A streptococcal vaccinesMoyle, Peter M., Dai, Wei, Zhang, Yingkai, Batzloff, Michael R., Good, Michael F. and Toth, Istvan (2014). Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group A streptococcal vaccines. Bioconjugate Chemistry, 25 (5), 965-978. doi: 10.1021/bc500108b |
